Browse the evidence

The metabolic effects of central ghrelin on adipose tissue are mediated by the sympathetic nervous system, as evidenced by the lack of metabolic response in mice lacking beta-adrenergic receptors.

The brain's command to store fat via ghrelin is sent through the sympathetic nervous system. Disrupting this pathway (as seen in specific genetic knockouts) blocks the fat-storage signal, highlighting the nervous system's role in hormonal fat regulation.

Endogenous satiation signals (like CCK) are subservient to long-term adiposity signals (leptin/insulin) and cannot cause long-term weight loss in free-feeding animals because they compensate by eating more frequently.

Your body's natural 'fullness' signals (like CCK) are not strong enough to keep you thin if you are genetically prone to obesity, because your body will just make you eat more often to compensate. This is why willpower alone often fails.

Telomere length is not a validated, universal biomarker of human aging because current evidence is equivocal, inconsistent across studies, and fails to predict mortality or functional decline better than chronological age.

Do not rely on telomere length testing as a definitive measure of your biological age or life expectancy. Current scientific consensus indicates the evidence is too mixed and inconsistent to be useful for individual prediction. Focus on established health markers instead.

Genomic instability and DNA damage accumulation are causative drivers of organismal aging and cellular senescence, rather than merely correlative byproducts.

Focus on maintaining genomic integrity through healthy lifestyle choices like caloric restriction, which has been shown to reduce oxidative damage and extend lifespan in models. Be skeptical of antioxidant supplements as a universal anti-aging solution, as evidence for their efficacy in healthy individuals is mixed or negative. Prioritize strategies that support DNA repair mechanisms and reduce chronic stress on cells.

Mitochondrial DNA (mtDNA) mutations cause premature aging in mice primarily through apoptosis and loss of irreplaceable cells, rather than through a vicious cycle of increased oxidative stress.

Be aware that mitochondrial DNA damage can lead to cell death (apoptosis) and tissue loss, not just oxidative stress. This suggests that maintaining mitochondrial function is important, but the mechanism might be more about preventing cell loss than just neutralizing free radicals.

Genetic overexpression of autophagy-related proteins (e.g., ATG5, LC3/ATG8) is sufficient to extend life span in model organisms.

In animals, genetically boosting autophagy proteins extends life. This proves that enhancing the body's natural cleanup system is enough to live longer. However, this is not a practical human intervention yet, as it requires genetic modification.

Adipose tissue-derived stem cells (ASCs) are perivascular cells (pericytes) located around blood vessels, characterized by specific surface markers such as CD146+, NG2+, and alpha-smooth muscle actin (alpha-SMA+).

ASCs are not randomly scattered; they are strategically located around blood vessels. This localization is key to their function in tissue repair and regeneration.

High-dose resveratrol supplementation (1500 mg/day) for 4 weeks produces no significant improvement in insulin sensitivity, substrate metabolism, blood pressure, or body composition in obese men.

Taking 1500 mg of resveratrol daily for a month will not improve your insulin sensitivity, lower your blood pressure, or change your body composition if you are obese. The supplement does not work for these metabolic goals in humans, despite what animal studies suggest.

Hyperactivation of PARP1 due to persistent DNA damage depletes cellular NAD+, which inhibits SIRT1 activity and leads to mitochondrial dysfunction, thereby accelerating aging and neurodegeneration.

Chronic DNA damage can drain your cells' energy resources (NAD+) by forcing them to constantly repair DNA. This impairs mitochondrial function. Strategies that support NAD+ levels (like exercise or potentially specific supplements, though not explicitly dosed here) might help mitigate this drain, but the primary goal is minimizing DNA damage.

Specific gut bacteria extend host lifespan by interacting with host nutrient signaling pathways (IIS and mTOR), and this extension is lost if these pathways are disabled.

Some gut bacteria can extend lifespan by interacting with your body's nutrient-sensing pathways (like IIS and mTOR). However, this benefit is not universal; it requires your specific host pathways to be functional. Maintaining these pathways through balanced nutrition is key to leveraging potential microbiome benefits.

Maternal exposure to high-fat diets during pregnancy programs fetal hypothalamic development to predispose offspring to obesity and metabolic complications, independent of maternal obesity.

A mother's diet during pregnancy, specifically high-fat intake, can program her child's brain to crave more food and store fat more easily. This happens even if the mother doesn't become obese. Pregnant women should prioritize balanced, low-fat diets to protect their child's long-term metabolic health.

DPP-IV inhibitors (e.g., sitagliptin) lack strong clinical evidence for improving NAFLD/NASH histology and may be ineffective in controlled trials, despite promising animal model data.

Do not rely on DPP-IV inhibitors (like sitagliptin) to treat your liver disease. While they help with blood sugar, controlled studies show they do not significantly improve liver fat or inflammation in NAFLD/NASH patients.

Pharmacological inhibition of mTOR via rapamycin extends lifespan across multiple model organisms, including yeast, nematodes, fruit flies, and mice.

This paper establishes that inhibiting the mTOR pathway, specifically via rapamycin, extends lifespan in various animals. While this is a key finding in longevity research, the paper notes that translating this to humans requires understanding the complex interplay with nutrient sensing and potential side effects, as rapamycin is an immunosuppressant.

In the context of preexisting severe obesity and adipose tissue dysfunction (ob/ob mice), blocking VEGF-A signaling reduces body weight gain, improves insulin sensitivity, and decreases inflammation by inducing apoptosis in dysfunctional, hypoxic adipocytes.

This study suggests that treatments targeting blood vessels in fat might help people with severe, established obesity by reducing the number of unhealthy, inflamed fat cells. This is a complex medical intervention and not a lifestyle strategy.

In utero exposure to famine or severe nutritional restriction increases the adult risk of hypertension, type 2 diabetes, and obesity, with risk magnitude dependent on the specific gestational timing of exposure.

If you were born to a mother who experienced severe food scarcity, your body may be biologically primed to store fat and regulate blood sugar differently than average. This is not a character flaw. Focus on consistent, moderate nutritional quality and regular physical activity to support your metabolic health, rather than extreme restrictive diets which may trigger further metabolic adaptation.

Non-coding RNAs (miRNAs, lncRNAs, circRNAs) regulate gene expression in metabolic diseases and serve as diagnostic/prognostic biomarkers and potential therapeutic targets.

Research into non-coding RNAs is leading to new diagnostic tools and potential drugs that can silence or enhance specific genes involved in metabolism, offering hope for treating conditions like obesity and diabetes.

Innate and adaptive immune cells (Kupffer cells, monocytes, neutrophils, T cells) are central drivers of NASH inflammation and fibrosis, with specific pathways like NLRP3 inflammasome activation and CCL2/CCR2 monocyte recruitment being critical for disease progression.

NASH involves active inflammation driven by immune cells, not just fat accumulation. Targeting immune pathways (like CCL2/CCR2 or NLRP3) is a key area of research for treating NASH.

Exogenous reactive oxygen species (ROS), specifically hydrogen peroxide (H2O2), accelerate adipocyte differentiation and mitotic clonal expansion by enhancing the DNA binding activity of the transcription factor C/EBPalpha.

This research explains the biological mechanism of how fat cells form, highlighting that a certain level of oxidative stress (ROS) is required for pre-fat cells to multiply and mature. It does not suggest that you should consume hydrogen peroxide or seek oxidative stress. However, it implies that excessive antioxidant supplementation might theoretically interfere with normal fat cell differentiation processes in the body, although this is observed in cell cultures, not necessarily in whole human physiology.

Ovariectomy leads to hepatic steatosis (fatty liver) driven by upregulation of PPAR-gamma and lipogenic genes, independent of dietary fat intake.

Menopause increases the risk of fatty liver disease through hormonal changes that activate fat-producing genes in the liver, even without eating more fat.

Adipocyte-derived fatty acids, released via lipolysis (ATGL/HSL), are taken up by breast cancer cells and drive proliferation and migration through increased fatty acid oxidation (CPT1A) and electron transport chain activity.

This research suggests that in obesity, fat cells release fatty acids that fuel breast cancer growth. While this is an in vitro finding, it implies that metabolic factors linked to obesity (like high fatty acid availability) may promote cancer progression. It does not currently translate to a specific dietary intervention for patients, but highlights the importance of metabolic health in cancer risk.

There is no consistent causal evidence that higher BMI or Type 2 Diabetes causes changes in chronotype or sleep duration, nor that chronotype or sleep duration causally affect BMI or Type 2 Diabetes, despite observed genetic correlations.

While poor sleep and obesity are linked, this study suggests that one does not necessarily cause the other. You may need to address both sleep hygiene and metabolic health independently, as they might share common genetic roots rather than a direct cause-and-effect relationship.

Administration of insulin-sensitivity-associated bacteria, specifically Alistipes indistinctus, ameliorates insulin resistance and improves glucose tolerance in high-fat diet-fed mice by reducing caecal monosaccharide levels.

Specific gut bacteria, such as Alistipes indistinctus, can help break down harmful sugars in the gut, potentially improving insulin sensitivity. This suggests that targeting specific bacterial strains could be a therapeutic strategy for metabolic health.

Administration of probiotics to critically ill patients with multiorgan failure or severe immunocompromise can increase bacterial translocation and cause sepsis, making it unsafe as a standard practice.

If you are critically ill, have multiorgan failure, or are in the ICU, do not take probiotics unless explicitly prescribed by your medical team. In these cases, probiotics can cause sepsis and death. Standard practice suggests avoiding them.

Blockade of central melanocortin receptors decreases glucose utilization in skeletal muscle and brown adipose tissue while increasing glucose uptake in white adipose tissue.

Your brain directs glucose to different tissues based on hormonal signals. When these signals are disrupted, your muscles may become less efficient at using glucose, while your fat cells become more efficient at taking it up for storage.